前药
化学
酯酶
组合化学
共轭体系
硫化物
酶
立体化学
硫化氢
生物化学
有机化学
硫黄
聚合物
作者
Yueqin Zheng,Bingchen Yu,Kaili Ji,Zhixiang Pan,Vayou Chittavong,Binghe Wang
标识
DOI:10.1002/anie.201511244
摘要
Prodrugs that release hydrogen sulfide upon esterase-mediated cleavage of an ester group followed by lactonization are described herein. By modifying the ester group and thus its susceptibility to esterase, and structural features critical to the lactonization rate, H2 S release rates can be tuned. Such prodrugs directly release hydrogen sulfide without the involvement of perthiol species, which are commonly encountered with existing H2 S donors. Additionally, such prodrugs can easily be conjugated to another non-steroidal anti-inflammatory agent, leading to easy synthesis of hybrid prodrugs. As a biological validation of the H2 S prodrugs, the anti-inflammatory effects of one such prodrug were examined by studying its ability to inhibit LPS-induced TNF-α production in RAW 264.7 cells. This type of H2 S prodrugs shows great potential as both research tools and therapeutic agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI